Skip to main content
Erschienen in: Reactions Weekly 1/2018

01.12.2018 | Case report

Avibactam/ceftazidime

Type 1 hypersensitivity reaction followed by successful desensitisation: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Davenport J, et al. RAPID DESENSITIZATION AFTER A TYPE I HYPERSENSITIVITY REACTION TO CEFTAZIDIME/AVIBACTAM IN A PENICILLIN TOLERANT PATIENT. Annals of Allergy, Asthma and Immunology 121 (Suppl.): S67 abstr. M012, No. 5, Nov 2018. Available from: URL: http://doi.org/10.1016/j.anai.2018.09.219 [abstract] - USA Davenport J, et al. RAPID DESENSITIZATION AFTER A TYPE I HYPERSENSITIVITY REACTION TO CEFTAZIDIME/AVIBACTAM IN A PENICILLIN TOLERANT PATIENT. Annals of Allergy, Asthma and Immunology 121 (Suppl.): S67 abstr. M012, No. 5, Nov 2018. Available from: URL: http://​doi.​org/​10.​1016/​j.​anai.​2018.​09.​219 [abstract] - USA
Metadaten
Titel
Avibactam/ceftazidime
Type 1 hypersensitivity reaction followed by successful desensitisation: case report
Publikationsdatum
01.12.2018
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2018
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-018-55529-y

Weitere Artikel der Ausgabe 1/2018

Reactions Weekly 1/2018 Zur Ausgabe

Case report

Multiple drugs

Case report

Paclitaxel

Case report

Multiple drugs

Case report

Tocilizumab